Killestein, Joep <br/><br/>
Emerging safety issues in alemtuzumab-treated MS patients.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  08 2019 
 - 1206-1208 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1477-0970 
<br/><br/><label>Standard No.: </label>10.1177/1352458519851219  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized<br/>Humans<br/>Incidence<br/>Multiple Sclerosis<br/>Multiple Sclerosis, Relapsing-Remitting